Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Giovanna Tedesco Barcelos, MA, MS
Senior Manager, HTA Value & Evidence, Sickle Cell Disease
Pfizer, Switzerland
Poster(s):
(303) Estimation of period-based costs associated with individual chronic complications of rare inherited diseases, in the context of multimorbidity, using real-world data.
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST